ICON plc (ICLR)
NASDAQ
Real-time Data
01:30 PM
Day's Range
159.1652 wk Range
66.57Overview - ICLR - ICON plc
Key Statistics
Valuation
Enterprise Value
15.10B
P/E (Trailing)
‪170.57‬
P/E (Forward)
‪13.70‬
PEG Ratio
‪-2.87‬
Price / Sales (TTM)
‪1.50‬
Price / Book
‪1.33‬
EV / EBITDA
‪28.84‬
Profitability
Gross Margin
‪23.22%‬
Profit Margin
‪0.32%‬
Operating Margin
‪9.41%‬
Return on Assets
‪0.96%‬
Return on Equity
‪0.28%‬
Ownership
Shares Outstanding
77.15M
Float
77.09M
Short % of Shares Outstanding
‪3.85%‬
Held by Insiders
‪0.44%‬
Held by Institutions
‪108.33%‬
Price stats
Beta
‪1.20‬
50-Day Avg
‪167.31‬
200-Day Avg
‪146.44‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
18 analysts
Average price target
‪$ 185.56‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ICLR - ICON plc
Peers - ICLR - ICON plc
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- TWSTNASDAQTwist Bioscience Corporation12.12BMarket Cap+85.23%52-week change-140.79P/E (Trailing)‪-31.66%‬Profit Margin
Profile Summary - ICLR - ICON plc
About
ICON plc is a clinical research organisation that provides outsourced drug and device development services to pharmaceutical, biotechnology, medical device, and public health customers. The company supports clinical development across the full product lifecycle, including study design, trial management, data…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
